CBD for PMS and Menstrual Pain

What is Premenstrual Syndrome (PMS)?

Premenstrual syndrome (PMS) refers to a group of physical, emotional, and psychological symptoms that affect many women, typically starting one to two weeks before menstruation. Recent research indicates that up to 75% of menstruating individuals experience some form of unpleasant menstrual-related symptoms, though the severity and specific symptoms vary greatly between individuals.

PMS is primarily attributed to the rapid fluctuations in female hormones—particularly estrogen and progesterone—that occur during the menstrual cycle. These hormonal changes can trigger a cascade of physiological and psychological responses that manifest as PMS symptoms.

Physical Symptoms

Bloating and abdominal discomfort
Menstrual cramps and pelvic pain
Breast tenderness
Headaches and migraines
Muscle aches and joint pain
Fatigue and low energy
Food cravings and appetite changes
Sleep disturbances
Acne and skin changes
Water retention and weight gain

Emotional and Psychological Symptoms

Mood swings and irritability
Anxiety and tension
Depression and sadness
Difficulty concentrating
Feeling overwhelmed or out of control
Social withdrawal
Angry outbursts

Premenstrual Dysphoric Disorder (PMDD)

Premenstrual Dysphoric Disorder (PMDD) is a more severe form of PMS, often featuring extreme irritability, drastic mood shifts, and feelings of hopelessness or anxiety. According to the Office on Women's Health, PMS affects about 90% of menstruating women at some point, while PMDD impacts an estimated 3-8% of women of reproductive age. PMDD is a clinically significant disorder that requires professional medical attention and may severely impact daily functioning.

The Endocannabinoid System and Menstrual Health

Recent research has revealed crucial insights about the relationship between the endocannabinoid system (ECS) and menstrual health. The human ovary actually produces the endogenous cannabinoid anandamide, such that in healthy women throughout the menstrual cycle the amount of anandamide circulating is high during the follicular phase from menstruation until ovulation, with levels highest during ovulation and lower during the luteal phase.

The endocannabinoid system is involved in gynecological functions, with differential expression of ECS genes supporting a cell type-specific endocannabinoid activity in the endometrium. This natural fluctuation of endocannabinoids throughout the menstrual cycle suggests that the ECS plays a fundamental role in reproductive health.

Estrogen makes it harder for an enzyme known as fatty acid amide hydrolase (FAAH) to complete its function—which is to break down anandamide. When we have more estrogen flowing, it blocks this breakdown process and lets anandamide do its thing, which includes reducing symptoms of anxiety and depression.

Latest Clinical Research on CBD and Menstrual Symptoms

Breakthrough 2024 Clinical Trial Results

The most significant advancement in CBD research for menstrual symptoms came from a 2024 randomized, open-label trial published in Experimental and Clinical Psychopharmacology. This groundbreaking study was the first to directly examine the effects of CBD on menstrual-related symptoms.

Study Design: Participants were assigned randomly to one of two dosing groups of CBD softgels (160 mg twice daily, n = 17; 320 mg twice daily, n = 16) and completed a 1-month baseline period before three months of CBD consumption.

Key Findings: Results revealed reductions (in both dosing groups) in menstrual-related symptoms, irritability, anxiety, global impression of change, stress, and subjective severity scores when comparing baseline to all 3 months of CBD consumption. Importantly, changes in symptoms appeared in the first month of CBD consumption and persisted over the 3 consumption months.

CBD Suppository Research

A significant 2024 survey-based, quasi-experimental study published in npj Women's Health assessed the use of a high-CBD (100 mg) vaginal suppository for menstrual-related pain and discomfort. The CBD group demonstrated significantly reduced frequency and severity of menstrual-related symptoms, impact of symptoms on daily functioning, need for analgesics, and number of analgesics used relative to the control group.

Correlation analyses indicated a potential dose-dependent response, with increased suppository use associated with greater reduction of symptoms. Most CBD participants reported at least moderate improvement of symptoms (72.9% at first follow-up, 81.1% at second follow-up).

Comparative Efficacy Research

A Phase II, non-inferiority trial is currently investigating the efficacy of cannabidiol versus ibuprofen in relieving menstrual pain in females with primary dysmenorrhea. The study aims to provide evidence that oral CBD alone is an alternative treatment for menstrual pain, particularly for women who do not respond to or have contraindications to NSAIDs.

Mechanisms of Action: How CBD May Help PMS

Pain and Inflammation Management

CBD's analgesic properties are well-documented through multiple mechanisms. Research from 2007 published in the European Journal of Pharmacology demonstrated that CBD reduces pain through two mechanisms: inhibiting the uptake of anandamide (involved in pain control through cannabinoid CB1 and CB2 receptors) and acting as an agonist of vanilloid TRPV1 receptors implicated in pain processing.

CBD's anti-inflammatory effects can help address the underlying inflammation that contributes to menstrual cramps and other PMS-related discomfort.

Mood and Anxiety Regulation

A 2017 review published in the British Journal of Pharmacology found that CBD presents powerful anxiolytic effects via at least two mechanisms: mediating the action of endocannabinoids on cannabinoid receptors in neural circuits involved with anxiety and fear memory, and interacting with serotonin 5-HT1A receptors targeted by anxiolytic and antidepressant medications.

This dual mechanism helps explain why CBD may be particularly effective for the mood-related symptoms of PMS and PMDD.

Gastrointestinal Support

A 2018 review in Biochemical Pharmacology concluded that CBD can regulate gastrointestinal motility in both physiological and pathological situations, including constipation, diarrhea, and IBS. CBD can also help reduce visceral sensitivity and abdominal pain via activation of CB1 and CB2 receptors.

Sleep and Circadian Rhythm Support

CBD appears to influence melatonin production, the hormone regulating sleep-wake cycles. By promoting more consistent sleep patterns, CBD may have far-reaching effects on overall hormonal health, as quality sleep is important for hormone regulation, immune function, and overall well-being.

Current Treatment Landscape and CBD's Role

Conventional Treatments

Traditional PMS treatments include:

NSAIDs: Help with pain and inflammation but may cause gastrointestinal side effects
Hormonal birth control: Can help regulate hormone fluctuations
Antidepressants: SSRIs are commonly prescribed for PMDD, with studies showing that both continuous and luteal phase dosing are efficacious
Diuretics: Help reduce bloating and water retention
Lifestyle modifications: Exercise, dietary changes, stress management

CBD as a Complementary Treatment

CBD offers several advantages as a complementary approach:

Multi-symptom relief: Addresses both physical and emotional symptoms
Fewer side effects: Generally well-tolerated compared to pharmaceutical options
Natural hormone support: Works with the body's endocannabinoid system
Flexible dosing: Can be used as needed or continuously
Multiple delivery methods: Oils, capsules, topicals, and suppositories available

Practical Considerations and Dosing

Dosing Guidelines

Based on the latest research:

The 2024 clinical trial used doses of 160mg twice daily or 320mg twice daily, with both showing efficacy
The suppository study used 100mg CBD per suppository with positive results
Start with lower doses (10-25mg) and gradually increase as needed
Consistency is key—regular use may be more effective than sporadic use

Delivery Methods

Sublingual oils: Fast onset (15-30 minutes), easy dose adjustment
Capsules: Convenient, consistent dosing, longer duration
Topicals: Targeted relief for cramps and muscle pain
Suppositories: Direct application to pelvic area, promising research results

Timing Considerations

Prophylactic use: Starting 1-2 weeks before expected symptoms
Symptom-onset dosing: Begin at first sign of PMS symptoms
Continuous use: Daily supplementation throughout the cycle

Safety and Contraindications

CBD is generally well-tolerated, but considerations include:

Drug interactions: CBD can affect liver enzyme metabolism; consult healthcare providers if taking other medications
Pregnancy and breastfeeding: Safety not established; avoid use
Quality concerns: Choose third-party tested products from reputable manufacturers
Legal status: Varies by jurisdiction; ensure compliance with local laws

Future Research Directions

The researchers noted that "further research is warranted comparing the effects of CBD to placebo (a limitation of the study) and examining the potential to optimize CBD consumption for reducing menstrual-related symptoms (e.g., combining CBD with terpenes; varying routes and timing of administration)".

Promising areas for future investigation include:

Placebo-controlled clinical trials
Optimal dosing and timing protocols
Combination therapies with terpenes or other cannabinoids
Long-term safety and efficacy studies
Personalized medicine approaches based on individual ECS function

Conclusion

The landscape of CBD research for menstrual health has evolved significantly since 2020, with the first direct clinical evidence now available. The 2024 study suggests that CBD may be an effective treatment in alleviating menstrual-related symptoms, with subjects experiencing immediate relief that was sustained over the course of the trial.

CBD's multifaceted mechanisms of action—including pain relief, mood regulation, anti-inflammatory effects, and sleep support—make it a promising complementary approach for managing PMS symptoms. The growing body of research, combined with CBD's generally favorable safety profile, suggests it may offer a valuable option for women seeking natural alternatives to conventional treatments.

However, it's essential to consult with healthcare providers before incorporating CBD into a PMS management plan, particularly for those with severe symptoms or PMDD. As research continues to evolve, CBD may become an increasingly important tool in the comprehensive management of menstrual health.

References

IN COOPERATION WITH MYDOSAGE

CBD for Health Conditions: Research & Applications

Discover evidence-based insights into CBD's therapeutic potential across various health conditions. Our articles are grounded in current research and written with scientific integrity.

Learn more